Khalil Abou‐El‐Ardat

1.6k citations
21 papers · 1.0k indexed · 1 hit paper · h-index 16
Topics
Acute Myeloid Leukemia Research (5 papers)Glioma Diagnosis and Treatment (4 papers)Hemoglobinopathies and Related Disorders (4 papers)
Partner nations
GermanyBelgiumNorway

In The Last Decade

Khalil Abou‐El‐Ardat

21 papers receiving 1.0k citations

Hit Papers

Association of Mutations Contributing to Clonal Hematopoi...20182026202020232018100200300

Peers

Khalil Abou‐El‐Ardat
Comparison fields: 5 of 103
  • Molecular Biology 371
  • Genetics 339
  • Hematology 329
  • Cancer Research 171
  • Oncology 149
Replace Maya N. Polackal with:
Maya N. Polackal United States
Irene A. Rigault de la Longrais Italy
Raechel Peralta United States
Abhishek Niroula Sweden
Ruben Bierings Netherlands
Maria Teresa Sabrina Bertilaccio Italy
Elizabeth A. Traxler United States
Samirkumar B. Amin United States
Stephen Tonna Australia
Takayoshi Matsumura Japan
Khalil Abou‐El‐Ardat relative to Maya N. Polackal United States Maya N. Polackal's profile →
Citations per field
00.5×3.2×
Maya N. Polackal · 1×
Citations per year

Countries citing papers authored by Khalil Abou‐El‐Ardat

Since Specialization
Citations

This map shows the geographic impact of Khalil Abou‐El‐Ardat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Khalil Abou‐El‐Ardat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Khalil Abou‐El‐Ardat more than expected).

Fields of papers citing papers by Khalil Abou‐El‐Ardat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Khalil Abou‐El‐Ardat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Khalil Abou‐El‐Ardat. The network helps show where Khalil Abou‐El‐Ardat may publish in the future.

Co-authorship network of co-authors of Khalil Abou‐El‐Ardat

This figure shows the co-authorship network connecting the top 25 collaborators of Khalil Abou‐El‐Ardat. A scholar is included among the top collaborators of Khalil Abou‐El‐Ardat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Khalil Abou‐El‐Ardat. Khalil Abou‐El‐Ardat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 31
2 26
3 6
4 170
5 1
6 24
7 2
8 52
9
Association of Mutations Contributing to Clonal Hematopoiesis With Prognosis in Chronic Ischemic Heart Failurebreakdown →
326
10 78
11 37
12 17
13 20
14 15
15 17
16 71
17 2
18 21
19 5
20 18

About Khalil Abou‐El‐Ardat

Khalil Abou‐El‐Ardat is a scholar working on Genetics, Applied Microbiology and Biotechnology and Cancer Research, having authored 21 papers that have together received 1.0k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (5 papers), Glioma Diagnosis and Treatment (4 papers) and Hemoglobinopathies and Related Disorders (4 papers). The work is most often cited by research in Genetics (339 citations), Hematology (329 citations) and Aging (38 citations). Khalil Abou‐El‐Ardat has collaborated with scholars based in Germany, Belgium and Norway. Frequent co-authors include Sebastian Wagner, Michael A. Rieger, Birgit Aßmus, Stefanie Dimmeler, Tina Rasper, Andreas M. Zeiher, Lena Dorsheimer, Jedrzej Hoffmann, Florian Seeger and Hubert Serve. Their work appears in journals such as PLoS ONE, Oncogene and The FASEB Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026